‘We are pleased to partner with Biogen Idec to expand their studies to additional sites. With the successful completion of the scholarly studies, we will have defined important components of ALS because of the C9orf72 gene carefully,’ Dr. Bruijn said, ‘and can thus be in a posture to launch a medical trial in people whose ALS is due to this gene.’.. 3 says take divergent paths about healthcare for poor Media outlets look back at the decisions made by Minnesota, Wisconsin and Texas leaders about expanding insurance coverage to the poor beneath the health rules and what which will mean for citizens living right above the poverty range.The Daily Health Plan Report is published for Kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. Copyright 2009 Advisory Table Kaiser and Company Family members Foundation. All rights reserved. These findings, based on a recent study, were presented during the 2005 annual meeting of the American Society of Clinical Oncology. The scholarly study comprised 830 sufferers with stage III cancer of the colon, who, simultaneously, were getting involved in another trial intended to evaluate two different chemotherapeutic regimens.